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Abstract? Positron? emission? tomography? (PET)? imaging? is? based? on? detecting? two? time-coincident? high-
energy? photons? from? the? emission? of? a? positron-emitting? radioisotope.? The? physics? of? the?
emission,? and? the? detection? of?the?coincident?photons,?give?PET? imaging?unique?capabilities? for?both?
very? high? sensitivity? and? accurate? estimation? of? the? in? vivo? concentration? of? the? radiotracer.? PET?
imaging?has?been?widely? adopted? as? an? important? clinical?modality?for?oncological,?cardiovascular,?and?
neurological? applications.? PET? imaging? has? also? become? an? important? tool? in? preclinical? studies,?
particularly?for? investigating?murine?models?of?disease? and?other? small-animal?models.?However,?there?
are?several?challenges?to?using?PET?imaging?systems.?These?include?the?fundamental?trade-offs?between?
resolution? and? noise,? the? quan-titative? accuracy? of? the? measurements,? and? integration? with? X-ray?
computed? tomography?and?magnetic?resonance? imaging.?In?this?article,?we?review?how?researchers? and?
industry?are?addressing?these?challenges.
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1. INTRODUCTION
In vivo structural imaging provides valuable data in clinical and preclinical studies, but to reveal
the true structures of the physiological time-varying processes that explain disease phenomena
it is necessary to combine morphological information with in vivo molecular imaging. Of all
the tomographic molecular imaging modalities, positron emission tomography (PET) imaging
probably offers more translational possibilities that any other modality due to its combination
of sensitivity and quantitative accuracy. PET is a noninvasive imaging modality that provides
physiological information through the injectionof radioactive compounds (radiotracers), detection
of radiation, and reconstruction of the distribution of the radiotracer. PET imaging has evolved
from an imaging modality used for research to become a standard component of diagnosis and
staging in oncology; it is also used for specific neurological and cardiovascular indications. This
is due to the clinically useful information that it provides about tissue and organ function, and
status, through the use of radiolabeledmolecular imaging agents.The type of informationprovided
depends on the imaging agent and the disease and can include detection, classification, staging,
prognosis, treatment planning, assessing response to therapy, and surveillance.
Combining PET imaging with the anatomical imaging delivered by X-ray computed tomog-
raphy (CT) or magnetic resonance imaging (MRI) provides the synergistic combination of infor-
mation about what (from PET) with information about where (from CT or MRI). In addition,
the anatomical information from CT and MRI can often be used to provide estimates of the
quantitative corrections needed for accurate PET imaging. These synergies, when combined with
advances in PET technologies, have led to a fertile area for the development of new imaging
methods and applications. This review outlines the technological advances made in clinical and
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preclinical PET imaging systems, as well as the major current challenges, and opportunities for
further advancement. These advances and challenges are summarized in Table 1.
2. THE?PHYSICS?OF?PET?IMAGING
The physics that enable PET imaging are based on the emission of a positron by a neutron-
deficient radioisotope. This is illustrated in Figure 1a for fluorine-18 (18F), the most commonly
used radioisotope. As the radioisotope decays to a stable state, the emitted positron travels a
short distance (typically 1–2 mm) and interacts with an electron; this interaction annihilates both
the electron and the positron, thus producing two high-energy photons. The photons travel in
opposite directions along an approximately straight line, and can be detected outside the body by
the PET scanner.
The detectors use scintillator crystals coupled to photomultipliers (discussed in Section 3). A
review of the properties of these detectors can be found in Reference 1. The first limitation in
PET imaging is the noise, which is driven by the number of individual 511 keV photons detected.
In turn, this is determined by the density of the scintillator, the count-rate capabilities of the
scanner, and the amount of radiation injected into the patient. The second limitation is the spatial
resolution, which is determined by the variability in estimating the interaction point of the 511 keV
photon in the scintillator. In turn, this is affected by the optics of the scintillator, the number of
optical photons emitted, and the fidelity of the photomultiplier tubes and associated electronics.
These factors impose the noise and resolution characteristics of the PET imaging process.
If two photons are detected in a short-coincidence time window (typically 1–10 ns), the joint
detection is called a true-coincidence event for the line of response (LOR) joining the two detectors
(Figure 1b). More accurately, the parallelepiped joining the two detector elements is called a tube
of response. The total number of true-coincidence events detected by the two detector elements
will be proportional to the total amount of radiotracer contained in the tube of response. This
is the key to PET imaging. Based on this relationship, one can process the coincidence events
to accurately reconstruct the distribution of the radioisotope. For time of flight (TOF) PET
imaging systems, the differential timing of the detection of the two photons is used to localize the
annihilation along the LOR.
However, before this can happen, confounding physical effects must be estimated and com-
pensated for. The most important confounding effects are patient-specific, and they have to be
reestimated for each scan; these confounding effects are attenuation, scattered coincidences, and
random coincidences (see Figure 2 and Section 4). It is also possible to consider the patient’s
motion (e.g., movements caused by respiration) as a confounding effect (Section 6). More detailed
descriptions of the physics of PET imaging can be found in Reference 2.
In practice, with patients or animals, a biologically functional compound is first labeled with
a positron-emitting radioisotope. Then the radiotracer is injected into the living subject, and
it preferentially accumulates where the compound is metabolized. The biodistribution of the
radiotracer varies over time, and this dynamic information is sometimes used to analyze the image
(Section 5).
3. NEW?DETECTOR?TECHNOLOGIES
Improvements to the quality of PET images are made by increasing the sensitivity and spatial
resolution of the image, which requires an array of detectors that can capture the largest possible
fraction of the photons emitted by the target object at the highest possible rate and with the best
possible spatial accuracy. In addition, the detectors should possess the highest possible energy
resolution to reduce the effects of scattered radiation (3).
3
Table?1? Positron?emission?tomography?(PET):?new?applications?and?their?readiness?for?implementation
New
technology Problem addressed Readiness level Application Comments
Faster and
cheaper
scintillators
Increases count-rate
performance, light output
(with higher energy and
better spatial resolution),
and usability; enables
time-of flight PET imaging
In production, widely
available
Cost reduction in
clinical scanners;
higher image quality
in preclinical systems
Radioactive isotopes in the
formulation introduce
background noise that could
limit the signal-to-noise
ratio in very low count
applications
Subsurface
laser
engraving of
scintillators
Facilitates the manufacture of
crystal arrays, reduces costs,
increases sensitivity by
avoiding the need for
reflectors in between
crystals
Prototypes are being
tested, mainly for
preclinical
applications
Clinical and preclinical,
but more relevant for
preclinical use due to
the higher complexity
of the crystal matrices
Great potential for
introducing alternative,
affordable coding schemes
for depth-of-interaction and
light sharing
Solid-state
photodetec-
tors
Reduces the cost of the
detectors; enables magnetic
compatibility for combined
PET–MR imaging
In production; several
manufacturers offer
alternatives and
yearly updates
Used in combined
PET–MR scanners;
they reduce the cost
of the PET gantry;
new applications may
be based on more
compact detectors
Semiconductor technology is
highly competitive; newer
and better devices will
appear, and their cost will
be reduced over time
Dual-energy
CT
attenuation
correction
Quantitative accuracy of
PET imaging
Already developed for
CT, but clinical need
for combined
PET–CT imaging
not demonstrated yet
Clinical quantitative
imaging
Already applied in preclinical
imaging, but no applications
yet
Scatter
correction in
systems with
long axial
extent
Larger field of view increases
the scatter fraction
To be developed Clinical systems Monte Carlo simulations and
single-scatter approximation
approaches will require
intensive computation
Clinical 4D
(time-varying
or gated)
imaging
Difficulty of adopting 4D
techniques into clinical
routines
Widely used for
preclinical
applications; already
adopted in some
clinical applications,
including cardiology
and planning for
radiation oncology
treatment
Relevant to any
imaging requiring
suppression of
respiratory-motion
effects
Clinical applications are
limited to simple models
due to limitations in the
signal-to-noise ratio;
movement suppression is
slowly being adopted
Multi-isotope
PET imaging
Limitations of
single-radiotracer imaging
Under development Simultaneous imaging
of different
physiological
processes
Several approaches have been
reported in the literature,
but none has been adopted
in clinical or preclinical
applications
PET–MR
imaging
Soft-tissue contrast in
anatomical imaging, e.g.,
brain
Commercially
available
Under development Attenuation correction issues
not completely resolved
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Figure?1
(a) Creation of two anticollinear 511 keV annihilation photons following positron emission by the radioactive decay of fluorine-18 (18F)
(half-life, 110 min). The neutron-deficient 18F isotope decays to the stable isotope oxygen-18 (18O) by converting a proton to a neutron
and thus emitting a positron (a process known as conservation of charge). After losing most of its kinetic energy via random scattering
while traveling a short distance (i.e., the positron’s range is 2 mm in this case), the positron encounters its antiparticle, the electron. The
resulting annihilation of both particles generates two 511 keV annihilation photons traveling in opposite directions. The small
deviations from 180◦ are due to random variations in the residual momentum at the time of annihilation. (b) Schematic of the positron
emission tomography (PET) imaging process. The patient is placed inside the gantry and surrounded by a ring of detectors that define
the scanner’s active sensor area. When two annihilation photons are detected within a few nanoseconds of each other, the two points of
interaction define a line of response. Because the detector’s elements have finite dimensions, the line of response schematically
represents the ensemble of coincidences that fall inside the tube of response, which is defined by the size of the detector’s elements.
Accordingly, new designs for detectors begin with new scintillator materials because this is the
preferred method for detecting annihilation photons. Scintillation crystals produce fluorescent
light after being excited by a 511 keV photon that has been scattered by or absorbed into
the crystal. The intensity of the pulse of visible light contains information about the energy
of the original photon that caused the scintillation. Therefore, annihilation photons can be
Lost (attenuated) event Scattered-coincidence event Random-coincidence event
Incorrectly determined LORs No LOR determined
Detected
photon
Compton
scatter
Figure?2
Confounding physical effects that cause bias in positron emission tomography (PET) coincidence imaging.
(Left to right) Attenuation: One of the annihilation photons does not reach the detector either because it has
undergone absorption or Compton scattering that deflects it away from the detectors or because it does not
interact in a measureable way with a scanner detector. Scattered-coincidence event: One of the two photons
undergoes Compton scattering and changes its trajectory, but both photons are still detected, thus defining
an incorrect line of response (LOR). Random-coincidence event: Two simultaneous annihilations produce
two pairs of photons; if for any reason two of the photons belonging to different annihilations are detected in
a time coincidence, they will define a randomly oriented (i.e., incorrect) LOR.
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characterized by detecting and counting the visible light photons with a photodetector. A good
scintillator crystal should have high stopping power for 511 keV annihilation photons and high
efficiency for converting the energy from the annihilation photon into detectable light; it is also
desirable that the resulting light pulse occurs within a very short time, and the intensity should be
proportional to the energy of the annihilation photon. The optical properties of the crystal are also
important: The crystal must be transparent to the wavelength of the fluorescent light to avoid
self-attenuation, the index of refraction must match that of the photodetector to optimize the
collection of light, and the crystal should be rugged enough to be processed and manipulated
during manufacturing.
Modern scintillators produce shorter andmore intense light pulses compared with earlier crys-
tals, such as BGO (bismuth germanate), which used to dominate PET-detector technology. BGO
has a high density and high atomic number, so the 511 keV photons have a large probability of
interacting with the crystal, but the BGO low light production limits the energy resolution of
the detector, thus resulting in more scatter in the final image, and its long decay time precludes
its use in applications with high count rates. Newer, more luminous, and faster scintillator crys-
tals, such as LSO (lutetium oxyorthosilicate) and LYSO (lutetium yttrium oxyorthosilicate) (4, 5),
have been used to build detectors that have better energy resolution and faster light decay times
that can reduce undesired effects, such as the piling up of events on the detector, degradation
of event timing, or background scatter. These new scintillators also enable clinical TOF PET
imaging (6–8), and they are being used in layered combinations (known as phoswichs)—of LSO,
LYSO, LuYAP (cerium-doped lutetium yttrium perovskite), GSO (gadolinium oxyorthosilicate),
LaBr3:Ce (cerium-doped lanthanum bromide), Ce:GAGG (cerium-doped gadolinium aluminum
gallium garnet) (9), and others (10)—in small-animal PET scanners to implement depth of in-
teraction (DOI) corrections on long crystals (11), which increases spatial resolution and reduces
parallax error (12).
A drawback of using scintillator crystals made from lutetium (176Lu) is that it is a radioactive
contaminant that produces a natural background coincidence count rate, which increases the noise
in low count-rate applications (13). Another drawback to using modern scintillators is their high
cost. Alternative ceramic scintillatorsmay ameliorate this limitation (for example, BaAl4O7:Eu2+);
although they are too slow for PET time-coincidence imaging, they compete with currently used
scintillator crystals when used for single-photon imaging (14).Themass production of transparent,
ceramic scintillators may make them more affordable than current scintillators, and this may open
new opportunities to confront the design of next-generation of PET scanners (Section 3.3)
Pixelated scintillator crystals covered by reflectors perform better as detectors than those that
use monolithic crystals (15). However, the need to individually manipulate the pixelated crystals,
and to paint or apply the reflector surfaces, make their production time consuming and expensive.
An alternative to using pixelated crystals is to usemonolithic crystals with sophisticated algorithms
to resolve the scintillation point of occurrence in 3D space (16). More recently, a process called
subsurface laser engraving (SSLE, also known as a laser-processed boundary) has been used to build
arrays of scintillator pixels from monolithic crystals (17, 18). Because an automated laser engraver
processes the crystals, manufacturing should become more affordable and reliable. In addition,
creating reflective surfaces using SSLE rather than by cutting material away, allows scintillation
material to be retained between crystals. As a result, the sensitivity of the detector is increased. A
further advantage of SSLE is that the shapes of detector elements can be optimized, for example by
combining continuous sections with pixelated ones that have been multilayered, tapered, or tex-
turized to introduce DOI encoding schemes (19). Finally, it should also be noted that 3D printing
techniques, using different materials, have been devised to efficiently manufacture reflectors and
light guides that extract the maximum light from monolithic and pixelated scintillator arrays.
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3.1.?Solid-State?Photodetectors
The mass production of semiconductor photodetectors in radiation detector engineering has
enabled new molecular imaging modalities, such as simultaneous PET imaging and MRI (20).
Different manufacturers name their photodetectors differently, depending on the manufacturing
process and mode of operation. Examples include the silicon photomultiplier, multipixel photon
counter, single-photon avalanche diode, and avalanche photodiode (21), all of which use a matrix
of individual photodiodes that operate in or near avalanche mode. The sum of the signals from
an individual diode is a measurement of the amount of light deposited in the array, and this, in
turn, is related to the light produced by the scintillator (Figure 3a). These new devices have had
important impacts ondetector design:Theyhave an improved, effective sensing area in comparison
with traditional photomultipliers; the time resolution increases their potential in terms of TOF
capabilities; their power requirements are lower; their packaging is more robust and compact; and
they are compatible with the high magnetic and electric fields present inside an MR scanner.
The digital photon counter (DPC) is a variant of conventional silicon photomultiplier (SiPM)
detectors, and it operates intrinsically in a digital mode (22). The DPC treats the signal from
individual photodiodes as the basic quantum of information and, instead of adding them in analog
mode, counts them to produce a digital code that is related to the number of photons (Figure 3b).
In principle, this method should produce noise-free data that are precisely timed with respect to a
master clock, thus producing high-resolution measurements of time. These novel characteristics
of the DPC have created high expectations about the performance of the PET scanners that use
them, and the first commercial clinical systems are appearing.
Detectors based on CZT (cadmium zinc telluride) do not use scintillators because they directly
convert ionizing radiation to charge production, providing higher energy and spatial resolutions
than scintillator-based PET detectors. However, their efficiency in detecting photopeaks and
their performance in terms of timing are lower. To overcome the lower efficiency in photopeak
detection, designers have stacked these devices, providing the additional advantage of gaining
DOI information. However, the poor timing performance and the complexity of the system are
difficult to compensate for, limiting the potential application of these devices (23).
In summary, the selective combination of these new scintillators coupled with silicon photo-
multipliers presents new alternatives for designing detector modules with very high energy and
spatial resolutions (<1mm), increased sensitivity, andmore accurate timing. These capabilities are
important in highly demanding applications, such as rubidium-82 chloride (82Rb) cardiac imaging
(24), oncological head and neck imaging (25), radiation therapy procedures in which detecting a
hypoxic region is crucial for determining prognosis, radioimmunotherapy imaging (26, 27), or for
the early detection of neurodegenerative dementias, for example by imaging tau proteins to detect
Alzheimer’s disease using highly specific radiotracers (28).
3.2.?Improved?Data-Acquisition?Systems
Signals coming from PET detectors carry information about the detected event in the charac-
teristics of the electrical pulse generated by the charge collection. After determining the precise
timing of the pulse’s arrival, the pulse’s waveform is integrated and digitized. In this process, the
full description of the original shape of the pulse is lost. However, it is known that the shape of the
pulse contains additional information that could be extracted and used to improve the processing
of the pulse and, in turn, the quality of the image reconstructed from the ensemble of pulses.
New, fast, free-running analog-to-digital converters are ubiquitous in modern communication
systems. They can be used to implement waveform digitization of the detector pulses, and from
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(a) (Left) Semiconductor photodetectors using an ensemble of photodiodes; in this case, a matrix of 20× 20 elements produces an
electrical analog signal that is proportional to the number of scintillation photons reaching the sensor. The signal is built by adding the
contributions of each individual photodiode avalanche. Three γ rays impinging on the three red pixels will produce a signal that is the
result of the addition of the three avalanches produced at each individual element. (Right) The output pulse is labeled in photoelectrons
(PE). Images courtesy of Hamamatsu Photonics K.K. (Hamamatsu City, Japan). (b) In digital photocounters, each individual signal
from each photodiode is treated as a discrete or integer (i.e., digital) increment. The time of arrival of the first scintillation photon at
the digital semiconductor photodetector (i ) marks the beginning of the period for counting the total number of arrivals during a given
interval (ii ). Once the period ends (iii), the total count of individual contributions becomes a digital number (iv) that is proportional to
the number of photons reaching the detector, and that number, in turn, relates to the energy of the γ-photon that originated the
scintillation. All processing is done using digital electronics. Drawings courtesy of Philips GmbH (Herrsching, Germany).
that, researchers can derive additional information that can be used by the binning and image-
reconstruction algorithms. This extra information can also be used, for example, to remove pulse
pileups in situations with a high count rate (29), in TOF imaging (30), and to implement DOI
correction (31).
An alternative to analog-to-digital converters is the time-over-threshold converter, which ob-
tains accurate information about timing and energy by converting the charge measurement to
a time measurement. This technique allows for significant simplification of the electronics by
reducing circuitry and power consumption, characteristics that become relevant to applications
such as handheld probes, MRI that is compatible with PET detectors, or large-scale systems with
a high number of channels. One of the drawbacks of the time-over-threshold method has been the
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(a) The time of flight (TOF) is defined as the interval between the arrival (t1 and t2) at their respective
detectors of the two photons resulting from the disintegration of the positron. Both photons travel at the
speed of light, and if positron annihilation occurs at the midpoint of the line of response (LOR), t1 will be
equal to t2. If that is not the case, then the time difference (t1−t2) can be translated into a distance from the
LOR midpoint to the most probable annihilation point, and that will be the location where the probability
density function should be centered (red ) for the disintegration occurrence used in the reconstruction model,
instead of using a less accurate uniform distribution (blue). (b) The detector sensitivity is directly proportional
to the crystal thickness, but thicker crystals produce larger cross sections when the LOR defined by the two
detectors in coincidence doesn’t cross the detector ring center. The resulting effect is a deterioration in the
effective resolution from the center (i ) toward the edges (ii ). The Gaussian profiles depict the LOR spatial
response to a point source placed in the center of the cross section: The narrower the cross section, the
better. A scintillator crystal that can estimate the depth of interaction (DOI) defines several LORs for the
same non-DOI LOR. This is depicted here for a two-layered crystal that defines two narrower LORs (iii )
instead of just one (ii ). Black dashed lines indicate the separation between the (blue) front layer and the (red )
back layer.
intrinsic nonlinearity of the method, although recent implementation has compensated for that
inconvenience, improving its performance to the point where it can be used in TOF systems (32).
In TOF PET imaging, the measurement of the precise difference in the arrival times of the two
511 keV annihilation photons (Figure 1) can be used to reduce uncertainty about the location of
the annihilation locus and thus improve image quality. In the situation depicted in Figure 4a, the
offset in distances from the annihilation point to the detectors causes a difference in detection times,
described by t = t2 − t1, albeit with some variability due to the timing resolution. This informa-
tion enables localization of the annihilation to a limited region between the two detectors. This
small time difference is described by t = 2d/c , where d is the distance from the scintillation to the
center of the segment defined by the two detectors, and c is the speed of light (6). Currently, detec-
tors and instrumentation technology in clinical scanners can provide a timing resolution no better
than 200 ps, which translates into a 3 cm spatial difference that is not small enough to allow direct
reconstruction of a high-resolution image. However, when TOF measurements are fed into the
reconstruction algorithms as a priori information, the image quality is significantly improved (33).
Another challenge of current detector technology is the DOI effect, or parallax error: This
appears when attempts are made to increase the sensitivity of a PET system by reducing the
diameter of the ring or increasing the thickness of the crystal. As the relative thickness of the
detector increases, the spatial resolution degrades increasingly as one moves from the center
to the edge of the field of view (FOV) (12). Such nonuniformity in resolution across the FOV
has adverse consequences for the visualization and the quantification of target activity. Different
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techniques can be used to deal with this problem by estimating the DOI: Previously mentioned
combinations of different scintillators can be used in a phoswich (34) (Figure 4b), or stacks of
photodetectors and scintillators with properly treated surfaces can be configured (35). Although
DOI is very important for high-resolution preclinical imaging, it may not be that relevant in
clinical scanners because its effect is small compared with the overall resolution of the scanner
itself. However, in high-resolution brain imaging, the DOI may become more important.
3.3.?System?Designs:?New?Geometries
An alternative to the basic PET scanner, which uses rings or ring sections of opposing detectors,
is to use different geometrical configurations for specific applications in different organs. These
geometrical configurations optimize the positioning of the detectors to improve spatial resolution
and sensitivity in the region of interest (ROI), thus increasing the detection ability and quantitative
accuracy of the resulting image. An example is the case of brain imaging, for which a proposal
based on the geometry of a helmet with the addition of chin detectors has been shown to increase
the supported solid angle of the scanner, thus maximizing its geometric efficiency (36).
A promising alternative to organ-adapted designs is the use of inserts or probes with high-
resolution detectors that can be used as magnifiers (37) to define virtual PET pinholes (38) or
implement zoom-in capabilities (39). In these configurations, a conventional PET scanner is
set in coincidence with the high-resolution insert detector or endoscopic probe in such a way
that the new set of LORs oversamples the area of interest. This new information is used by the
reconstruction algorithm to complement the simultaneous collection of standard data performed
by the detector ring in such a way that the ROI can be reconstructed with higher resolution and
sensitivity. This approach may not be as optimal as using customized geometry, but it has the
advantage of improving imaging in the breast (40, 41), prostate (42), and other organs of interest
using existing PET scanners, with investment needed only for an additional imaging probe.
Whole-body (WB) PET imaging is an option that could benefit from technological advances
(43). Currently, WB imaging is achieved by moving the patient’s bed from head to toe, thus
exposing different body sections to the detectors and then stitching together those sections to
present aWB image. The problems with this approach are obvious: Different parts of the body are
scanned at different time points; thus, there are differing biodistributions of the radiotracer. The
idea of covering the full length of the human body with detectors (44, 45), or even with a spherical
PET scanner (46), is not new, but there has been a revival of interest in WB PET imaging. This
is motivated by its potential to evaluate the pharmacological kinetics of new imaging radiotracers
in different organs of interest simultaneously as well as by the tremendous increase in sensitivity
that occurs due to the much larger, solid angle. However, the increase in sensitivity comes with an
increase in the scatter fraction along with the requirement for a data-acquisition system capable
of coping with enormous event rates. Initiatives are being undertaken to address these issues as
well as the high cost of building WB scanners with available technology. A recent study evaluated
many of these issues, trying to optimize the design of a viable WB scanner (47).
4. NEW?ALGORITHMS?FOR?IMAGE?RECONSTRUCTION
AND?DATA?PROCESSING
4.1.?Quantitative?Corrections
Ensuring? quantitative? accuracy? requires? estimating? the? confounding? effects? described? in?
Section? 2.? These? include,? in? rough? order? of? effect? size:? attenuation;? random? coincidences;
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scattered coincidences; patients’ movements; geometry-based variations in efficiency; the system’s
dead time; radioisotope decay time and branching ratio; detector resolution; and variations
specific to the detector element in efficiency, signal gain, coincidence timing, energy resolution,
and event positioning. A description of these effects is beyond the scope of this review, but useful
overviews are provided in References 48 and 49.
These effects must first be estimated before they can be corrected. Scanner-dependent effects
can be complex and time-consuming to estimate, but in general they require only infrequent
updates—for example, quarterly, annually, or only once for a class of scanners using calibra-
tion procedures. Patient-dependent confounding effects, however, have to be estimated for each
imaging session, and so are much more time sensitive. There is no fixed guideline for process-
ing times because images are analyzed and interpreted after the imaging session. However, a
useful rule of thumb for clinical systems is that to prevent delays in the data queue, the total
time for image processing and reconstruction should match the duration of the imaging session.
Clinical imaging sessions typically last from 30 to 60 min, depending on local protocols. For
preclinical or research imaging protocols, there is much more flexibility, depending on scan-
ner usage. Here we focus on three patient-dependent effects that present unique challenges:
attenuation, scattered coincidences, and random coincidences. Respiratory motion is covered in
Section 6.2.
4.1.1.?Attenuation.? Stand-alone?PET?systems?(i.e.,?those?used?without?CT)?obtain?their?atten-
uation?maps?of?a?transmission?scan?by?rotating?a?positron-emitting?rod?source?around?the?subject?
(2).?However,?with?the?advent?of?combined?PET?and?CT?scanners?roughly?15?years?ago,?stand-
alone?PET?scanners?have?disappeared?from?the?clinical?market.?The?standard?approach?used?by?
dual-mode?PET–CT?scanners?is?to?convert?the?CT?image?to?attenuation?coefficients?for?511?keV?
photons?using?a?bilinear?transformation?with?different?scale?factors?for?soft?tissue?and?bone.?This?
approach?has?also?been?applied? to?preclinical? imaging?systems? that?have?separate?PET?and?CT?
scanners.?The?bilinear?transformation?method?is?based?on?the?observation?that?the?mass?attenua-
tion?coefficient?(the?linear?attenuation?coefficient?divided?by?density)?is?the?same?for?all?soft?tissue?
but?not?for?bone,?due?to?the?higher?photoelectric?absorption?cross?section.?In?addition,?the?atten-
uation?of?PET?coincidence?data?at?511?keV?primarily?occurs?due?to?Compton?scattering,?which?is?
determined?by?density,?so?the?mass?attenuation?coefficient?for?all?materials?at?511?keV?is?constant.?
Thus,?only?scale?factors?for?bone?and?soft?tissue?are?needed?(50).?Although?this?works?well?for?soft?
tissue,?CT-based?attenuation?correction?is?challenging?in?bone?imaging?and?when?nonbiological?
materials? are?present,? such? as? iodine-based? contrast? agents,? implants,?or?other?devices? (51).? In?
addition,?when? combined?PET–MRI? scanners? are?used? then?CT? is?not? available,? as? is? further?
discussed? in?Section?6.?To? address? the? challenges?of?CT-based? attenuation? correction,? several?
multienergy?algorithms?have?been?developed?for?use?in?both?clinical?and?preclinical?imaging.?The?
fundamental?physics?are?illustrated?in?Figure?5,?which?shows?three?closely?related?components:?
the?CT?and?PET?transmission?spectra?of?photon?fluence?versus?energy,?and?the?mass?attenuation?
coefficients?over?the?s ame?energy?r ange.?Note?that?a ir?and?water?a re?very?s imilar,?unlike?bone?
and? iodine.?Also? shown? are? corresponding?measured? attenuation? images? for? a?20? cm?diameter?
water?cylinder?with?5?cm?cylindrical?inserts?containing?air,?a?bone-equivalent?solution?of?calcium?
chloride?(CaCl2),?and?diluted?iodine.?Iodine?and?barium-based?contrast?agents?are?commonly?used?
with?CT?scans?to?enhance?organ?delineation?and?perfusion.?Note?that?at?511?keV?the?cylindrical?
insert?containing?diluted? iodine?has?essentially? the?same?attenuation?coefficient?as?water,?but?at?
CT?energies? it?exhibits?a?noticeably?higher?attenuation,?and?the?relative?amount?of?attenuation?
compared?with?one?depends?on?the?peak?kilovoltage?(kVp)?setting.?The?PET?transmission?image?
is?nosier?and?has?lower?resolution?than?the?CT?images,?but?it?has?far?lower?bias?(50).
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(a) Computed tomography (CT) and positron emission tomography (PET) transmission energy spectra.
The purple and orange spectra correspond to the typical polychromatic emission of a standard X-ray tube
operating at 80 peak kilovoltage (kVp) and 140 kVp, respectively, and the monochromatic blue spectra is
the 511 kV emission from one of the photons resulting from a positron–electron annihilation. (b) Mass
attenuation coefficients μ/ρ (note the log scale) versus energy for four different media; notice the variations
that occur as a function of the energy. (c) Measured attenuation images for a water cylinder with inserts
containing air, a bone-equivalent calcium chloride (CaCl2) solution, and diluted iodine. The CT difference
image in Hounsfield units (HU) and a PET transmission image done at 511 keV (from annihilation photon
energy) show how the resulting attenuation image from which the attenuation map will be derived will differ
unless the correct energy scaling is used.
By using two CT scans with different energy ranges (e.g., 80 and 140 kVp), several approaches
have been developed to provide more accurate attenuation correction. The first of these includes
classifying iodine versus bone using the principles illustrated in Figure 5. This approach can be
used to account for soft tissue, bone, and any third material, such as iodine (52).
When there are more than three types of materials, alternative methods based on the seminal
dual-energy CT method developed by Alvarez & Macovski (53) can be used. In the modified
dual-energy approach, the raw data from the two CT scans are decomposed using material basis
functions, which are then separately reconstructed. The two basis images are then converted to
attenuation images at 511 keV using known material properties (54).
These dual-energy methods, and their variations, suffer from noise amplification in the es-
timated attenuation image due to the large degree of similarity between the two data sets. In
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principle, the noise can be mitigated through the use of iterative image-reconstruction methods,
similar to those described in Section 4.2 (55). Over the past few years, manufacturers have suc-
cessfully introduced dual-energy CTs that use different approaches (56, 57); however, these in-
novations have not yet been introduced on the CT components of combined PET–CT scanners.
Although there is an obvious advantage in the accuracy of the attenuation correction, the clinical
need has not been demonstrated. This may change as attention is increasingly paid to quantita-
tive accuracy in PET imaging (58, 59). It is interesting that CT-based attenuation correction has
been used for a decade in preclinical PET–CT scanners (60) and that dual-energy CT methods
have been successfully applied in preclinical imaging systems (61). However, we are not aware of
dual-energy CT-based attenuation correction being applied to the preclinical use of PET–CT
scanners.
4.1.2. Scatter. The second major quantitative correction is for the Compton-scattered photons
that are detected in coincidence; the Compton scattering reduces contrast. In modern PET sys-
tems these Compton-scattered photons can account for 30–50% of the desired true coincidences.
Because photons can undergo multiple scatters prior to detection, scatter is most accurately esti-
mated using Monte Carlo photon-tracking simulations (62). However, these simulations are still
computationally intractable (63). The distribution of scattered photons can be estimated much
more quickly by using single-scatter approximation (SSA), which can be analytically calculated us-
ing theKlein–Nishina equation, as first proposed by Barney et al. (64). This analytical SSAmethod
has been accelerated and extended by others (65–67) and has replaced all other scatter-estimation
methods used for clinical and PET–CT scanners and preclinical scanners (68). Although the SSA
method works well for objects with uniform attenuation, it is less accurate for cases in which there
is nonuniform attenuation, such as in the lung (66). A remaining challenge for the SSA method
is that most implementations neglect scatter that occurs outside of the transaxial plane. However,
newer commercial systems with longer axial extent have oblique angles that are larger by a factor
of 2 (69, 70), which may potentially invalidate the small-angle approximations used to date, but
this remains to be evaluated. Finally, we note that the SSA method can be extended to TOF PET
imaging, albeit with an added requirement that computing the ray integrals between detector pairs
will depend on the position along the ray, thus increasing computation time by a factor of 3 to 7
(67).
Random-coincidence events from the detection of photons from separate annihilations also
leads to reduced image contrast. The most common method for estimating the rate of random
events is to use theproduct of the singles counting rates for a givendetector pair and the coincidence
time window. This provides an accurate and noise-free estimate of the random-coincidence rate
for all LORs (71).
The estimates for attenuation, scattered coincidences, and random coincidences can be directly
used to correct the rawdata to give an estimate of true-coincidence events, or the corrections can be
incorporated in the iterative reconstructionmethods described in Section 4.2. The latter approach
is preferred because this preserves the Poisson statistical distribution of the raw data.
4.2.?Image?Reconstruction
The goal of PET image reconstruction is to provide cross-sectional images of the radiotracer
distribution within an object by using the coincidence events detected by a scanner. Detailed
mathematical formulations of the problem are presented in several reviews (48, 72, 73). There are
several important differences between PET image reconstruction and most other tomographic
imaging modalities (e.g., CT, MRI, ultrasound), the first being the Poisson statistical distribution
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General process for iterative tomographic image reconstruction. A key characteristic is the alternation back and forth between (left) the
data space and (right) the image space. The process starts with the raw data acquired from positron emission tomography (PET) and an
initial estimation of the reconstructed image, f(0), which can be derived from the acquired data, by assuming a uniform distribution, or
by another method. The first image estimation is projected into the raw data space (i.e., it is a forward projection that simulates the
data-acquisition process), and the result is compared with the measured PET data. Differences are used to calculate updates, which are
projected back into the image space (i.e., back projection is the adjoint operation to forward projection). This produces an updated
image estimate, f(1). The process is repeated until the difference in estimates of sequential images reaches a convergence criteria
previously defined, or a preset number of iterations occurs. Although several hundred variations of iterative algorithms have been
proposed, common approaches are now used.
of? the? measured? data.? This? distribution? enables? the? use? of? an? accurate? noise? model? in? the?reconstruction?process,?
but? only? if? the? raw? data? have? not? been? precorrected—for? example,? for? attenuation,? scattered? coincidences,? and?
random? coincidences.? The? second? difference? is? the? redundancy?of? the? acquired?data,?which? can?be?understood?by?
analyzing?a? sampling?of? the?Fourier? transform? of? the? object,?which? leads? to? unique? image-reconstruction? algorithms?
(72).?There?are?two? classes? of? image-reconstruction? algorithms:? analytical? and? iterative.?Analytical? algorithms?are?fast?
and?well?understood?due? to? their? linearity.? Iterative? algorithms? are? slower? and?nonlinear;?thus,? their?behavior? is?often?
poorly?understood.
Despite their drawbacks, the use of iterative algorithms is becoming standard in most clinical
and preclinical imaging due to their ability to suppress statistical noise by modeling the statistical
distribution of the raw data, as well as their ability to include more detailed models of the imaging
physics and radiotracer distribution. Additionally, advances in computer speeds havemade iterative
approaches feasible, following the rule of thumb described above—that is, the total time for image
processing and reconstruction should match the typical duration of the imaging session. For this
reason, we focus on iterative image-reconstruction algorithms, starting with a model of the image
process as the matrix equation g = Hf, where f = ( f1,, f j ,, fM
)
is an M-dimensional
vector representing the image values, and g = (g1,, gi ,, gN ) is an N-dimensional vector
representing the photon count data from the PET detector. The system model H has elements
Hij that represent the probability that a photon pair emitted from voxel j is detected by the i-th
pair of detectors. Thus, the matrix equation g = Hf presents a forward projection of the image
values into the data space. In general, the systemmodelH is very large (e.g., N ×M ≈ 106×108),
so the Hij elements are computed as needed, and several methods are used to reduce computation
time. The general process of iterative image reconstruction is illustrated in Figure 6.
Because the PET data have a Poisson distribution, the equation above models only the average
behavior of the imaging system, and amore accurate description isE{g} = Hf, whereE{·}denotes
the expectation operator. To preserve the statistical properties of raw PET data, the estimates for
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the confounding effects of attenuation (A), scattered coincidences (s), and random coincidences
(r) can be included in the forward projection step as E{g} = AHf + s + r. To make use of
the known statistical properties of raw PET data, the most widely used approach is maximum-
likelihood (ML) estimation. This is a standard statistical method that produces an estimate that
maximizes the likelihood function. This gives an estimated image that would have most likely
led to the data that were actually measured. The use of such iterative reconstruction methods
based on statistical principles can lead to improved image signal-to-noise ratios (SNRs). The most
useful methods are, in some manner, connected to the expectation maximization (EM) algorithm,
which is an efficient algorithm for finding themaximum likelihood (ML) estimate.Thus,maximum
likelihood–expectationmaximization (ML-EM) image reconstruction usesMLas the optimization
criterion and the EMalgorithm to find the optimal solution. TheEMalgorithmwas first described
in detail in 1977 (74) and was introduced for emission-tomography reconstruction in 1982 (75).
A key step on the path to clinical feasibility was the development of ordered-subset ML-EM
[typically called OSEM (76)], which increases algorithmic speed by factors of roughly 20–30.
These developments, along with increased computational power and fast numerical forward-
projection algorithms (77), have enabled the routine clinical use of statistical iterative algorithms
that suppress statistical noise in images.
5. APPLICATION?DEVELOPMENTS
5.1.?Time-Varying?Imaging
The imaging theory described so far assumes that the object and the radiotracer distribution are
stationary. In practice, the radiotracer distribution changes over time, and there is patient motion,
which can include cardiac motion, respiratory motion, and general motion. Depending on the
degree of change during the imaging period, there is the potential to extract more information
from the PET images if motion is included in the analysis or otherwise compensated for. If the
radiotracer distribution changes over time but the patient is otherwise stationary, the imaging is
typically referred to as dynamic imaging. If the radiotracer distribution is constant but the patient
moves substantially in a regular pattern owing to respiratory or cardiacmotion, then gated imaging
methods can be used to suppress motion artifacts. The suppression of respiratory motion effects
is discussed in Section 6.2, and similar methods are used to compensate for cardiac motion.
5.1.1.?Acquiring?dynamic?images.? Static?3D?PET?images?represent?a?single,?static?snapshot?of?
the?distribution?of?the?radiotracer?at?a?given?time.?Applications?in?drug?development,?cardiology,?
neurology,?or?oncology?often?require?an?understanding?of?the?dynamics?underlying?the?process?of?
radiotracer?biodistribution?in?order?to?reveal?the?true?biochemical?process,?and?this?information?
cannot?be?obtained? from? static? imaging.?The? trade-off? that?occurs?with? the? simplicity?of?using?
static?imaging?is?that?the?dynamic?information?related?to?the?kinetics?of?the?radiotracer?is?lost?for?
further?analysis.
Dynamic imaging (or 4D imaging, or time-varying 3D) is a PET imagingmode inwhich instead
of acquiring a single, fixed-time 3D image, a series of 3D images (frames) are individually registered
at different intervals, creating a time-varying sequence, which is the 4D image (that is, 3D plus
time). The 3D sequences can be analyzed by extracting the time–activity curves (TACs) that
describe the radiotracer accumulation in a specific voxel or group of voxels. TACs can be studied by
using kinetic modeling analysis for the radiotracer biodistribution (78), which results in a valuable
descriptionof the physiological parameters governing the radiotracer uptake.Examples of applying
this technique include imaging cardiac perfusion using 13N-ammonia or 82Rb, monitoring the
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Dynamic analysis of data from positron emission tomography (PET) is used to determine critical metabolic, transport, and
proliferation variables. (Left) The standard protocol relies on delineating regions of interest (ROIs) on a summed PET image
reconstructed using the imager model, or a coregistered anatomical image (from computed tomography or magnetic resonance).
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input to the kinetic-modeling programs that estimate physiologically relevant parameters for each of the tissues defined in the kinetic
model. The reconstruction step could be avoided by redefining the objective function used for the reconstruction process: In the
standard indirect model, the objective function is the relationship between the projection data sets measured by the PET system and
the 3D image sequence, and that information is contained in the imager model. (Right) In the direct estimation method, the new
objective function relates the projection data sets measured by the PET imager to the kinetic parameters defined in the kinetic model.
This new parametric model solves directly for the kinetic parameters and produces less noisy estimations of the physiological variables.
Modified from a figure courtesy of Mark Muzi, University of Washington. Other abbreviations: AIF, arterial input function;
CE, contrast-enhancing; NCE, non-contrast-enhancing.
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 The time resolution of the data acquisition compared with the time characteristics of the
physiological process: The 3D PET frame requires a minimum amount of accumulated
counts, and thus an acquisition time that is long enough to reach an acceptable SNR. If
the time required for imaging is longer than the transients of the radiotracer kinetics in the
tissue, the relevant dynamic information will be lost. Myocardial perfusion imaging using
82Rb is an extreme example in which the radiotracer’s dynamics and the isotope’s half-life
require very short time frames in the 4D imaging process; thus, the resulting sequence is
difficult to analyze due to a lack of counts per frame.
 The confounding results from resolution loss and spillover between the tissue of interest
and the blood pool or other adjacent tissues: This problem is present on any PET image. In
static images, the activity of the background due to the blood pool is low, but in the early
frames of a dynamic study all of the activity is in the blood pool, although this situation
changes at later time points. The redistribution of the radiotracer affects the spillover in a
different manner at different time points.
 The assumptions made during the kinetic modeling itself: Modeling, by definition, is a
simplification of real phenomena, and in the case of PET the data-limited SNR limits the
capability of the numerical algorithms to resolve the kinetic model.
 The difficulty of measuring the arterial input function that is required for the kinetic model-
ing process in order to provide quantitative results (79): The most commonly used method
for measuring arterial input function relies on obtaining arterial blood samples form the
patient throughout the duration of the scan. This is an invasive and costly procedure that
precludes the widespread use of kinetic modeling in clinical applications. Newer approaches
that try to extract the same information from the data set (such as the image-derived input
function) are still under development.
Other important issues are errors that arise owing to unavoidable patient movement originated
by respiration, the heartbeat, or involuntary muscular movements (80).
In conclusion, 4D PET imaging provides more complete and valuable information than does
static 3D imaging, but challenges remain, including the need to optimize acquisition protocols to
collect data of sufficient quality—which are needed to obtain enough information to perform the
kinetic modeling—and the increased complexity of data processing. These challenges will need
to be addressed before dynamic 4D PET imaging can permeate into clinical practice.
5.1.2.?4D?processing? and?kinetic? analysis.? The?conventional?analysis?of?data? from?4D?PET?
imaging?proceeds?in?four?steps:?time?framing,?3D?image?reconstruction?of?each?frame,?ROI?seg-
mentation?on? a? time-integrated? image?or?an?anatomical? reference? (such? as?a? registered?CT?or?
MR? image),? and,?finally,?k inetic?modeling.?The?f raming?r esulting?f rom?t he?first?two?st eps?is ?a?
time-varying?sequence?with?a?single?3D?image?per?time?point.
The size of the timebins becomes a critical parameter in ensuring there are sufficient samples for
theTACwhile simultaneouslyminimizing the number of time points (frames). If the physiological
process being studied is known, one can optimize the duration of the frames by choosing short
time frames for the initial fast section of the TAC, when the activity in the FOV is high because of
the first pass of the initial bolus, and by using longer time frames later, when biological washout
has cleared part of the radiotracer from the FOV and slow kinetics dominate the TAC plot
(Figure 7).
The third step, segmentation, produces ROIs fromwhich theTACs are obtained, representing,
for example, the time-varying uptake of radiotracer in tumor tissue or perfusion in an organ.
The complexity in this step stems from the tedious and error-prone manual segmentation or
definition of the ROIs on the image sequences, which challenges even experienced investigators
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in sequences with low SNRs. Automatic image segmentation offers a potential solution to this
problem, especially the techniques that provide more than simple anatomical ROI identification.
These algorithms may be based on principal-component analysis or multidimensional clustering,
in which the time–activity voxels and the spatial arrangement of those voxels are considered in an
iterative segmentation process before being assigned to a given cluster that defines an ROI (81,
82). New combined PET–MR imaging systems offer an alternative that ameliorates the difficulties
of segmentation by taking advantage of the high contrast of soft tissue provided by MRI to help
define the ROI.
An interesting alternative to the conventional protocol—which is based on image-domain
segmentation and TAC generation, followed by kinetic modeling analysis—is the generation of
parametric images from the raw sinogram or LOR histogram data by means of direct estimation
without previous image reconstruction (83, 84). Direct estimation can be used to reformulate the
reconstruction process described in Section 4.2, solving for the kinetic parameters instead of the
image itself, thus combining kinetic modeling with a scanner model into a new model (Figure 7).
More recently, direct-estimation methods have begun to incorporate corrections for patients’
movements (85). The computational cost of these methods is high, and although they are still
under development, preliminary results suggest they offer several advantages: When applied to
challenging models, such as dynamic myocardial perfusion with 82Rb used to evaluate coronary
flow reserve, the method produced results with improved resolution and contrast recovery and
also reduced quantitative bias (83). Better precision and lower bias have also been found for brain-
receptor imaging (84) with these methods.
5.2.?Dosimetry?and?Image?Monitoring
Targeted radionuclide therapy for cancer treats the disease by administering radiopharmaceuticals
that selectively deliver the radiation dose to the targeted tissue. The accuracy of 3D patient-
specific dosimetry depends on the quality of the 3Ddose estimations.These estimations are usually
obtained using a combination of single-photon emission computerized tomography (SPECT) and
CT images that enable estimation of tumor volumes and 3D imaging of radionuclide distribution
over time.
PET imaging is becoming a potentially useful tool for dosimetry in therapeutic procedures
because it can provide 3D estimations of many radiolabeled therapeutic and imaging agents.
As an example, iodine-131 (131I)-labeled antibody for therapy can be combined with iodine-124
(124I) for PET imaging in patients with thyroid cancer, in a process in which 3D PET imaging–
based dosimetry provides dose–volume histograms of the absorbed dose, and therefore of the
tumor’s response and of toxicity in normal organs (86). Similarly, yttrium-90 (90Y) TOF PET
imaging is used to precisely quantify 90Y-DOTATOC (edotreotide) in somatostatin-receptor-
based radionuclide therapy; it is also used on microspheres for radioembolization of liver tumors
(87), even though the 90Y branching ratio for pair production yielding PET events is extremely
low (34 disintegrations per min) (88).
Knowledge of the 3D distribution and quantification of a radiopharmaceutical are needed
to accurately estimate the efficacy of the treatment. The development of new, optimized PET
imaging protocols has provided valid dosimetry procedures that are compatible with clinical
practice in terms of the time required for preparation and acquisition (89). PET imaging is
particularly useful for precisely parameterizing lesion TACs to estimate the cumulated activity
concentration of a lesion usingmonoexponential models (90). However, there remain a significant
number of cases in which PET imaging fails to predict the uptake of radiotherapeutic agents (91).
The challenges remaining for imaging dosimetry in targeted radionuclide radiotherapy or in
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charged particle-beam therapy are in predicting and correcting the positron range of the isotopes
used and in providing better scattering estimation and correction, issues that are exacerbated by
unavoidable patient movement.
5.3.?Multi-Isotope?PET
Multi-isotope imaging is a common protocol in SPECT imaging and is used to visualize two
different physiological processes simultaneously. This is done by administering two radiotracers
with isotopes whose photon emissions have different energies. The isotope images are disentan-
gled with the appropriate energy windowing for each isotope. However, this technique is based
on distinguishing between different photon energies and will not work in standard PET imag-
ing because all annihilation photons resulting from positron annihilation have the same energy
(Figure 1). To overcome this limitation, alternative techniques have been proposed, including
the following:
 simultaneous injection of or sequential close-in-time injections of two radiotracers that do
not interfere with each other (92);
 dynamic imaging of timed injections followed by constrained kinetic modeling to separate
the particular dynamics of each radiotracer (93) using generalized factor analysis of the
dynamic sequences (94); or
 the use of a combination of radiotracers, one of which emits an additional ray photon
simultaneously with the annihilation photons. The two radiotracers can be differentiated by
measuring the energy of the third photon (which has to be different from 511 keV) (95).
A recent proposal is to use what has been termed the triple coincidence, whichworks with any third
photon because it can be distinguished from random or scatter; therefore, the triple coincidences
can be included in iterative reconstructionmodels (96). Events coming from triple-photon isotopes
can be detected separately from pure positron emitters using precalculated double-coincidence
probabilities that are used to assign the triple event to one of the possible LORs. Then, by label-
ing two compounds, one with a pure positron emitter and other with a complex-decay isotope,
simultaneous multitracer imaging can be done (Figure 8) without losing sensitivity or image qual-
ity. Because this method does not require specialized detectors or additional energy-resolution
requirements, it is being explored for implementation on clinical scanners (97). Simultaneously
imaging several molecular or physiological targets using different radiotracers may provide valu-
able prognostic information and improve disease diagnosis and classification. Some examples of
these applications include the simultaneous evaluation of tumor hypoxia and perfusion, which
have been demonstrated to impact the efficacy of chemotherapy and radiotherapy, the determi-
nation of tumor grade in patients with neuroendocrine tumors, or the simultaneous evaluation of
myocardial angiogenesis and hypoxia or metabolism (98).
6. MULTIMODALITY?IMAGING
In the late 1980s and early 1990s, several investigators conceived the idea of a multimodal medical
imaging system that could merge the more readable anatomical images from CT and MRI with
the functional information provided by PET (or SPECT). After a period of development [and
skepticism (99)], a new range of imaging tools was enabled by combining different modalities.
Pairing anatomical and functional information increases the accuracy of the information, and
different combinations of modalities have been proposed in the literature. However, only some of
these—specifically the combinations of PET and CT, PET andMRI, and SPECT and CT—have
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Multi-isotope in vivo brain positron emission tomography and computed tomography (PET–CT) imaging.
All images show the same approximate anatomical slice in the three orthogonal views (columns). CT image
values are represented using a gray scale, and PET image values are represented using a rainbow color scale.
(Top row) Standard PET image (using only double coincidences) from a rat injected with iodine-124
(124I)-β-CIT (dopamine transporters) and 18FDG (glucose metabolism). Because standard PET data
processing does not allow signal multiplexing, the combined signal from both radiotracers is shown as a
single, mixed image. (Middle row) Separated 18FDG signal obtained by multiplexed PET (mPET) showing
homogeneous uptake in the brain and a high, nonspecific uptake in the Harderian gland (H), which is typical
of this radiotracer. (Bottom row) Separated 124I-β -CIT signal obtained by mPET showing specific, dopamine
transporter binding in the striatum (S) and nonspecific uptake in the thyroid glands (Th). The top row shows
the result of adding information from the middle and bottom rows; mPET is capable of separating both
independent components. Images courtesy of Stephen Moore, Brigham and Women’s Hospital, Boston.
proven to be of clinical and commercial interest. In preclinical imaging, similar considerations
are applicable, albeit with a broader range of combinations of PET, SPECT, MRI, and CT, and
even triple-modality systems (100). As articulated by Cherry (101), multimodality systems should
provide added value, such as addressing scientific or clinical questions that would be impossible
to answer using separate scanners, or improving throughput for clinical or preclinical studies.
However, the use of multimodality systems comes with trade-offs between imaging performance
and cost when compared with stand-alone systems, and the use of multimodality systems requires
expertise across both, or all, of the combined modalities.
6.1.?PET–CT?Imaging
The?primary?goal?of?using?combined?PET–CT?imaging?is?to?accurately?align?the?PET?and?CT?
images,?which? provide? complementary? information? on? function? (PET)? and? anatomy? (CT),? as
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(a) Schematic and photograph of a combined positron emission tomography and computed tomography
(PET–CT) scanner used for clinical applications. Although the concept of aligning in tandem a CT scanner
and a PET scanner is simple, the technical and practical complexities pose challenges that range from the
footprint size of the resulting system to the spatial and temporal alignment of the resulting data sets. (b, left to
right) The coronal view of a clinical 18FDG PET scan clearly shows a recurrent thyroid cancer tumor
(crosshair), the CT image shows detailed anatomy in which the tumor is hardly distinguishable, and the
blended image shows the precise anatomical localization (from the CT image) of the active tumor (from the
PET image).
illustrated in Figure 9. Clinical PET–CT imaging has demonstrated its added value, and it is a
now the standard approach for diagnosing and staging many cancers (102). Near-simultaneous
PET and CT imaging provides information that is not available in separate PET and CT scans;
thus, it improves the assessment of the primary tumor, and nodal and distant metastases (103).
Although PET–CT imaging is primarily used in oncology, it has also been used to identify brown
fat (104), which potentially has important implications for metabolic disorders related to diabetes.
It also has applications in clinical and research cardiology (105). Preclinical PET–CT imaging
has also become a standard imaging tool that is used in studies using mouse models (106). The
structure of a typical PET–CT scanner is shown in Figure 9. As discussed in Section 4, a CT
image can also be used as the basis for correcting attenuation and scatter, along with offering
substantial reductions in transmission imaging time and other secondary benefits (50).
Although in a combined system the PET and CT images are nearly simultaneous, they cannot
be acquired contemporaneously because the CT X-ray photon flux would overwhelm the PET
detector system. Thus, there is a short time delay (e.g., approximately 30 s) between the CT
image—which is typically acquired first—and the PET image. This allows for the possibility of
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Simulated coronal slice of a human torso obtained by positron emission tomography (PET) illustrating the
impact of respiratory motion effects during combined acquisition of PET and computed tomography (CT)
data. (Left) If there is no motion, the lung tumor, liver boundaries, and the left ventricle of the heart are well
delineated. (Right) However, when respiratory movement is present, the blurring and mismatches in
attenuation correction introduce artifacts and numerical errors, which also obscure clinical evaluations.
motion occurring between the CT and PET images. Such motions, when they do occur, can lead
to different errors.
1. An unknown spatial offset between the CT and PET images can lead to a change in the
diagnosis or in staging criteria. For example, it may be difficult to differentiate whether a
lung tumor is near to, or invading, the chest wall or pleura.
2. An error may also arise from a shift in the attenuation correction, especially if PET radio-
tracer uptake occurs near a boundary between tissues that have large attenuation differences,
such as the top of the liver or the skin surface.
3. If there are artifacts or errors in the CT image, these will propagate to the PET image
through the attenuation-correction process.The impact of these artifacts on thePET images
is hard to predict a priori because the attenuation- correction process and the iterative image-
reconstruction algorithms are nonlinear (107).
In addition to the delay occurring between the acquisition of the CT and the PET images, the
images themselves also require different durations. A modern CT scanner can acquire an image
similar to that shown in Figure 9 in a few seconds (e.g., approximately 10 s), but PET scanners
may require 5–20 min, depending on the acquisition protocol. These differences in the duration
of acquisition time can lead to errors due to respiratory motion, which are discussed in the next
section.
6.2.?Respiratory?Motion?in?Multimodality?Imaging
Multimodality imaging of the lung and abdomen requires consideration of respiratory motion.
There are two major respiratory motion effects in PET–CT imaging. The first is the blurring
caused by respiratorymotion during the acquisition of PET images, which leads to shape distortion
and loss of signal. The second effect, described in the previous section, is the potential for a
positional mismatch between the different modalities, which can impact the use of CT images to
correct attenuation in the PET data. A mismatch in PET–CT imaging is illustrated in Figure 10,
where a detailed computer simulation shows several effects that result from a patient breathing
during a PET scan and from using a single breath-hold CT for attenuation correction. Although
the tumor is still clearly visible, its shape and values are distorted (108), as is the left ventricle, both
of which might impact the tracking of disease status.
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(Left) Cross section along the patient scan axis for an integrated inline design used by clinical positron
emission tomography–magnetic resonance (PET–MR) scanners. The PET detectors are placed between the
different MR coils to reduce cross-system interference. (Right) PET–MR image of an anaplastic thyroid
carcinoma formed from an MR T2-weighted turbo inversion recovery magnitude image showing high
contrast in the soft tissue ( gray) fused with an 18FDG PET image (color). Courtesy of Siemens Healthcare
and University Hospital of Tubingen.
Considerable efforts have been made to develop methods to compensate for the effects of
respiratory motion (109). The most direct approach is to use phase-matched respiratory-gated
CT and PET images to jointly solve for both blurring caused by respiratory motion and a PET–
CT mismatch. One of the difficulties with this approach, however, is the multitude of noisy
images that are produced. This has led to the development of more sophisticated methods that
remove respiratory-motion artifacts of both types while preserving quantitative accuracy without
increasing noise (52).
Similar considerations apply to combined MR and PET imaging. Although the multimodality
aspects of compensation for respiratory motion with PET–MR imaging are less advanced, MR
imaging does offer the potential of using simultaneous PET and MR imaging to provide accurate
respiratory-gating signals (110).
6.3.?PET–MR?Imaging
Although combined PET–CT scanners quickly became established as clinical tools, the develop-
ment of combined PET and MR imaging has been slower because of technical challenges arising
from both modalities when they are paired. The potential value gained by combining PET and
MR imaging is attributed to the superior capabilities ofMR for soft-tissue imaging compared with
CT, as well as the different types of imaging that can performed. Additionally, unlike PET–CT
imaging, PET–MR imaging is capable of achieving truly simultaneous imaging. This is enabled
by its integrated inline design, which is shown in cross section in Figure 11.
The simultaneous acquisition of PET and MRI data was first demonstrated in vivo in small
animals in the late 1990s (111). Initially, most of the progress in the field was made in preclinical
scanners. It took a full decade for the first imaging systems for human brains to be developed.
These systems had poor PET imaging performance (112) butwere a key step in developing the cur-
rent WB systems in clinical use. With the introduction of clinical PET–MR scanners, early work
has focused on comparing the diagnostic value of PET–MR images with those from PET–CT
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imaging. Published studies of PET–MR imaging demonstrate that the PET image data are some-
what comparable to those obtained from PET–CT scanners (113). However, the equivalency of
standardized uptake value quantification from PET–MR scans has been variable (114). Two im-
portant technical challenges that have not yet been resolved are attenuation correction for and
calibration of the PET scanner.
6.3.1.?Attenuation?correction.? For?combined?PET–CT?imaging,?the?attenuation?factors?can?be?
conveniently?derived?from?the?CT?image?because?the?same?processes?affect?photon?scattering?in?
PET?and?CT.?For?MR?imaging,?however,?the?image?values?typically?represent?a?weighted?average?
of?hydrogen?proton?density?and?T1?and?T2?relaxation? times,?which?are? influenced?by?the?local?
environment?(115).?This?mismatch?between?the?physics?of?PET?and?MRI?means?that?there?is?no?
simple?scaling?method?that?can?be?used?to?convert?the?MR?image?to?a?CT-equivalent?attenuation?
map.?The?current?approach? to?attenuation?correction,?which?circumvents? the?different?physics?
of?PET?and?MR? imaging,? is?to?use? image?segmentation?to?discriminate?between?air,? lungs,? fat,?
and?soft?tissue?in?the?MR?image,?and?then?assign?estimated?attenuation?coefficients?to?the?regions.?
Although?this?approach?can?lead?to?errors?in?estimating?the?uptake?of?PET?radiotracer?in?bone,?it?is?
currently?the?most?robust?method?for?estimating?PET?radiotracer?uptake?in?the?lung?from?PET–
MR?data?(116).?Several?other?methods?have?been?proposed?for?using?the?MR?image?to?estimate?
the?attenuation?image?(117).?In?general,?there?are?trade-offs?between?reliability?and?quantitative?
accuracy,?especially?when?estimating?radiotracer?uptake?in?bone.?This?is?an?active?area?of?research?
and?development.
6.3.2.?PET? calibration.? For?PET–CT? imaging,?PET?calibration?and?quality?control?are? sim-
plified?by?the?use?of?water-filled?phantoms.?However,?this?is ?challenging?because?MR ?images?of?
water-filled?phantoms?show?artifacts?and?inhomogeneities?when?imaged?at?the?3T?field?strength?
of?current?PET–MRI?systems?(118).?This,?in?turn,?causes?challenges?for?MRI-based?attenuation?
correction?(described?above).?The?search?for?fluids?other?than?water—for?example,?oil—is?chal-
lenging?because?FDG?does?not?dissolve?well?in?oils?(119).?Phantom?fluids?that?enable?image?quality?
testing?in?PET,?MRI,?and?PET–MRI?hybrid?imaging?are?currently?under?development?and?will?be?
a?necessary?step?toward?standardization?of?calibration?and?qualification?procedures?in?PET–MRI.
The immediate value of PET–MRI in oncology, not surprisingly, appears to come from the
improveddiagnostic information regarding soft-tissue lesions that is obtained from theMRimages.
In these cases, PET is the first option for clinical functional imaging because it is considered the
most sensitive technology, but for the anatomical component, MRI is becoming an alternative to
CT because of the higher contrast resolution for soft tissue. Further potential applications are
reviewed in Reference 120.
7. SUMMARY
Before the full potential of the sensitivity and accuracy of PET imaging can be exploited, challenges
must be resolved, including the limited SNR, the development of cost-effective technologies, and
the development of efficient workflows for clinical and research imaging. These limitations arise
not only from the physics of PET imaging but also from limitations in the technology.
The continued introduction of new detector technologies that use new, faster scintillators,
along with the introduction of semiconductor detectors, has enabled simultaneous hybrid PET–
MR imaging. Recent advances in processing scintillator crystals and coupling these to photode-
tectors have improved the performance of scanners built using these technologies, enabling new
applications in cardiology, oncology, neurology, and pediatrics.
24
Advanced algorithms that can be used for image reconstruction and correction are improving
the accuracy of quantitative imaging, and more sophisticated CT techniques, such as dual energy
CT, have been successfully applied in preclinical imaging. Scatter and random effects, which have
historically limited the image SNR, are being corrected by incorporating improved estimations
of these effects in iterative image-reconstruction methods. These new, albeit computationally
intensive, algorithms are demonstrating improved quantitative properties and improved lesion
detection.
Improvements in detector technology combined with enhanced image-reconstruction algo-
rithms are enabling clinical applications of 4D (that is, 3D plus time) imaging, kinetic modeling,
dosimetry, and even multi-isotope PET applications that provide more complete and accurate
information about the physiology being studied.
Finally, multimodality imaging has been widely adopted by the scientific community as a way
to gain a more comprehensive understanding of the effects of diseases and treatments. The PET–
CT revolution has initiated a new way of looking at physiology and morphology simultaneously,
and the new class of PET–MR systems is broadening the landscape of opportunities for clinical
and preclinical applications, while at the same time presenting new challenges for clinicians using
PET–MR systems and the engineers who are developing them.
The continued introduction of new detector technologies, hybrid imaging, and advanced algo-
rithms for image reconstruction and analysis make it clear that there will continue to be exciting
developments in the technology. These developments will both address the challenges and enable
new uses of PET in research and clinical imaging.
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